6 Jul 2020
Combating immunity to AAV Ensuring as many patients as possible can benefit from gene therapy The Duchenne Research Fund has awarded a grant to Dr Barry Byrne and Dr Manuela Corti’s team at the University of Florida, whose vital work focuses on overcoming...
7 Feb 2019
CRISPR for Duchenne Genome editing technology to correct the mutated dystrophin gene The Duchenne Research Fund awarded a £200,000 grant to the team at the Hospital for Sick Children in Toronto, Canada (‘Sick Kids’), to work on using CRISPR/Cas9 technology...
18 Dec 2016
Vamorolone Alternative to existing steroids for all with Duchenne In January 2024, vamrolone became the first drug for all people with Duchenne muscular dystrophy to be approved in the US, the EU and the UK. In December 2024, it was approved by NICE for use on the...